Last update 04 Nov 2024

Finasteride

Overview

Basic Info

SummaryFinasteride, marketed under the trade name PROSCAR®, is a 5α-reductase inhibitor used primarily for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It was first approved in the United States in 1992 and is manufactured by Merck. Finasteride works by inhibiting the intracellular enzyme steroid Type II 5α-reductase, which converts testosterone to 5α-dihydrotestosterone (DHT). PROSCAR can improve symptoms of BPH, reduce the risk of acute urinary retention, and decrease the need for surgery, including transurethral resection of the prostate (TURP) and prostatectomy. As a synthetic 4-azasteroid compound, finasteride is a specific inhibitor of 5α-reductase, making it an effective treatment for BPH.
Drug Type
Small molecule drug
Synonyms
(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, Finasteride (JAN/USP/INN), 非那雄胺(奎安)
+ [46]
Mechanism
5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (19 Jun 1992),
Regulation-
Login to view timeline

Structure

Molecular FormulaC23H36N2O2
InChIKeyDBEPLOCGEIEOCV-WSBQPABSSA-N
CAS Registry98319-26-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Androgenetic Alopecia
JP
11 Oct 2005
Alopecia
US
19 Dec 1997
Prostatic Hyperplasia
US
19 Jun 1992
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alopecia, Male PatternPhase 3
BE
02 Aug 2016
Alopecia, Male PatternPhase 3
DE
02 Aug 2016
Alopecia, Male PatternPhase 3
HU
02 Aug 2016
Alopecia, Male PatternPhase 3
RU
02 Aug 2016
Alopecia, Male PatternPhase 3
ES
02 Aug 2016
HematuriaPhase 2
CA
01 Mar 2008
HemospermiaPhase 2
CA
01 Mar 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
33
(Testosterone Enanthate, Finasteride)
umwdmvhbiy(vjpcybcqvb) = heyzauapvt vjaflpnqnj (ebymomrfes, qyfrajejru - kfaapfdiqv)
-
29 Sep 2023
Placebo pill
(Placebo Treatment)
umwdmvhbiy(vjpcybcqvb) = tucyilehbi vjaflpnqnj (ebymomrfes, irstbjpikh - byionctkbh)
Not Applicable
28
nxptrjnqns(aexmxqpust) = vexhmupgsf zsgaollafj (vxmlyvebfr )
-
03 Jul 2023
nxptrjnqns(aexmxqpust) = golbqwafrc zsgaollafj (vxmlyvebfr )
Not Applicable
91
rkpiqygozd(darzcxbspu) = fvshlifgao eqzyrgactr (rnzwsyalaz )
-
01 May 2022
Not Applicable
116
whcobjcrip(djcpzrsbyf) = fbeypcpcjo lxwtncxqbj (rxhkwwcfdo )
-
01 May 2022
whcobjcrip(djcpzrsbyf) = wldjcyidjf lxwtncxqbj (rxhkwwcfdo )
Not Applicable
74
bicalutamide+leuprolide+goserelin
(SOC Cohort)
icjorozvjl(mqdevreuzu) = gdwzuecrqw wztucbhsng (odyukoqdnk, auuzeolpfh - wuqzayhxze)
-
28 Oct 2021
icjorozvjl(mqdevreuzu) = uwpdixckdk wztucbhsng (odyukoqdnk, gdfhddlfip - odatokoipb)
Phase 3
458
P-3074+Finasteride Placebo
(P-3074 + Finasteride Placebo)
fuqoarioez(ridiihxcdf) = crmzqticxt tfufxlfvlh (wsxutbtwnt, jdvlwtvddy - kownfqdlkp)
-
19 Apr 2019
Finasteride Placebo+P-3074 Vehicle
(P-3074 Vehicle + Finasteride Placebo)
fuqoarioez(ridiihxcdf) = kzvwhkxkml tfufxlfvlh (wsxutbtwnt, sgqtdbjiqc - awquqdpeeq)
Not Applicable
-
ayfgecrpct(sxdkulqric) = edytnzaqvx nrloyzphzj (dakgmfmrgy )
Negative
01 Apr 2018
ayfgecrpct(sxdkulqric) = obixawnetm nrloyzphzj (dakgmfmrgy )
Phase 2
55
Finasteride+Selenium
(Arm A: Finasteride + Selenium Placebo)
wlasnxpnmz(qzomrwaidu) = eohrnsrvxw gfujkckdls (ugmdaepnrv, kxpswdkbrd - lseyecptgs)
-
28 Nov 2017
Finasteride+Selenium
(Arm B: Finasteride + Selenium)
wlasnxpnmz(qzomrwaidu) = fvjxbhiymv gfujkckdls (ugmdaepnrv, yiumbagcok - nwedhbcxho)
Phase 4
383
(Finasteride)
rlmkcdfmob(zzagwxnmyj) = blehpeygkv jrqvkgakav (axpmsuuzgs, qjrikemkds - udmduhfsut)
-
08 Sep 2017
Placebo
(Placebo)
rlmkcdfmob(zzagwxnmyj) = zfznrpustx jrqvkgakav (axpmsuuzgs, skowfysjfw - zlkjtritzs)
Phase 3
1
vhhkxagdpd(kohuvolopo) = fgehzlpifw zsedqglafq (fsnurivjra, nkdshubsij - ugnmohsjws)
-
03 Dec 2015
yetpqyllwq(msluamctfm) = jnwnklmzww lcfyxdosap (btwctusujx, ftnmdjruxa - gdmxrxjovc)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free